Your PT-141 strategy should prioritize injection unless needle phobia proves insurmountable, accepting nasal spray as valid alternative when convenience and needle avoidance justify 3x cost premium and reduced consistency, or maintaining both options with injection primary and nasal spray for travel or special situations
Some may experience mild nausea or digestive discomfort, especially early on
An analysis of nearly 10,000 people taking semaglutide drugs found they lost on average 10.2-13.2% of baseline weight over 12 months.(8) Its important to note that GLP-1 clinical trials employ run-in periods where non-adherent participants are excluded.(9) Real world patients face many barriers to consistent adherence, including side effects, injection anxieties, medication costs and behavioral challenges
These should include: Weight and BMI monitoring to assess treatment effectiveness Blood pressure checks , as weight loss can affect blood pressure Review of side effects and overall treatment tolerance Periodic blood tests as clinically indicated, which may include HbA1c (for diabetes monitoring), liver function tests, and renal function When to seek urgent medical advice: Symptoms of severe hypoglycaemia (confusion, loss of consciousness, seizures) Severe, persistent abdominal pain, which could indicate pancreatitis (a rare but serious side effect of GLP-1 receptor agonists) [2] [7] Sudden right upper abdominal pain, fever, or jaundice, which could indicate gallbladder disease (risk increased with rapid weight loss) Persistent vomiting leading to dehydration Signs of allergic reaction (rash, swelling, difficulty breathing) Symptoms of thyroid problems (lump in the neck, hoarseness, difficulty swallowing) Quality considerations for berberine supplements are important, as these products are not subject to the same regulatory oversight as medicines
Recent studies have shown trizepatide tends to trigger the largest weight loss
